We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.7B
$30.8M 0.77%
127,347
+121,866
+2,223% +$32.1M
KR icon
27
Kroger
KR
$35.4B
$29.9M 0.75%
814,052
-3,216
-0.4% -$116K
WFC icon
28
Wells Fargo
WFC
$258B
$29.7M 0.74%
627,305
-21,123
-3% -$1.03M
CSCO icon
29
Cisco
CSCO
$448B
$29.2M 0.73%
1,019,476
+378,164
+59% +$10.6M
ORLY icon
30
O'Reilly Automotive
ORLY
$71.3B
$29.1M 0.73%
1,608,855
-53,070
-3% -$938K
CLX icon
31
Clorox
CLX
$11.7B
$27.2M 0.68%
196,360
+24,501
+14% +$3.18M
MO icon
32
Altria Group
MO
$113B
$25.5M 0.64%
369,379
-1,496
-0.4% -$95.8K
FISV
33
Fiserv Inc
FISV
$28.8B
$25.4M 0.63%
467,170
-1,270
-0.3% -$65.4K
EA icon
34
Electronic Arts
EA
$52.9B
$25.1M 0.63%
331,733
-55,535
-14% -$3.91M
IWM icon
35
iShares Russell 2000 ETF
IWM
$80.2B
$24.4M 0.61%
212,293
-26,930
-11% -$3.04M
MXIM
36
DELISTED
Maxim Integrated Products
MXIM
$24.4M 0.61%
683,110
+95,582
+16% +$3.51M
INGR icon
37
Ingredion
INGR
$6.33B
$24.3M 0.61%
187,517
-276
-0.1% -$32.1K
BAC icon
38
Bank of America
BAC
$433B
$24.1M 0.6%
1,815,235
-183,735
-9% -$2.58M
HELE icon
39
Helen of Troy
HELE
$649M
$23.1M 0.58%
224,990
-975
-0.4% -$98.4K
SYY icon
40
Sysco
SYY
$40.6B
$23.1M 0.58%
455,648
+130,023
+40% +$6.29M
JAZZ icon
41
Jazz Pharmaceuticals
JAZZ
$16.2B
$22.8M 0.57%
161,318
+133,038
+470% +$19.6M
CVG
42
DELISTED
Convergys
CVG
$22.7M 0.57%
907,522
-5,241
-0.6% -$141K
QCOM icon
43
Qualcomm
QCOM
$159B
$22.6M 0.57%
422,770
+130,184
+44% +$6.86M
PFE icon
44
Pfizer
PFE
$142B
$21.8M 0.54%
651,369
-1,930
-0.3% -$61.6K
GE icon
45
GE Aerospace
GE
$368B
$21.7M 0.54%
143,888
-8,209
-5% -$1.2M
POOL icon
46
Pool Corp
POOL
$6.93B
$21.7M 0.54%
230,670
-3,155
-1% -$284K
MRK icon
47
Merck
MRK
$321B
$21.6M 0.54%
392,161
+328,096
+512% +$17.5M
BRK.B icon
48
Berkshire Hathaway Class B
BRK.B
$1.1T
$21.4M 0.53%
147,800
+140,685
+1,977% +$20.1M
MS icon
49
Morgan Stanley
MS
$330B
$21.3M 0.53%
821,395
+220,974
+37% +$5.78M
CMI icon
50
Cummins
CMI
$87.3B
$20.9M 0.52%
186,148
+184,083
+8,914% +$20.9M
1
2
3 4 5

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.